Introduction
Ageing is often associated with progressive disability, with unique environment and genetics impacting age-related functioning. 1 Among the mood disorders, bipolar disorder (BD) is associated with functioning within or below the functioning levels of the most chronic illnesses; 2 moreover, it could increase age-related impairment through both genetic and environmental pathways. An increased allostatic load associated with BD would anticipate such an association. 3 This concept is akin to cumulative physiologic dysregulation and allows for the prediction of changes in physical and cognitive functioning. 4 To our knowledge, an independent impact of bipolar disorder on age-related functioning has yet to be demonstrated in a controlled study. We evaluated this effect, with matched healthy subjects as a standard against which age-related impairment was measured.
Method
One-hundred outpatients with a confirmed diagnosis of BD according to the Structured Clinical Interview for DSM-IV and healthy controls individually matched for gender, age and years of education were consecutively recruited from September to November 2007. The only ground for exclusion was the inability to provide informed consent. Thus, patients were representative of patients treated for bipolar disorder in a tertiary health care centre. Compared to other outpatients in the Bipolar Disorders Programme of the Hospital de Clínicas de Porto Alegre 5 (n = 260), the patients in this study were not significantly different in terms of their age (44.23 vs 42.63), gender (74% vs 70% female) and number of hospitalizations (3.57 vs 3.57). All participants gave their written informed consent before entering the study, which was approved by the local ethics committee.
Functional impairment was assessed using the Functioning Assessment Short Test (FAST), an interview that evaluates disability. It includes items on autonomy, work, cognitive functioning, financial issues and interpersonal relationships. It has excellent reliability and was checked regarding content, construct and concurrent validity in Brazilian and Spanish populations. 6, 7 We used multiple linear regression with robust estimation of variances in the patient and control groups separately to test for age effects on functioning. In these analyses, effects were controlled for potential disability-related confounders, 8 such as medications currently in use and affective symptoms, which were assessed using the Hamilton Depression Rating Scale, the Young Mania Rating Scale and the Hamilton Anxiety Rating Scale and hospitalizations. We also tested inthe model years since diagnosis and years since specific treatment, but these were not predictive of functioning. Coefficients (β) and standard errors (SE) from these regressions were used to generate effect sizes. Heterogeneity, that is, how much the groups differ was investigated with the Q statistic. When the p value for this statistic is low (below conventional levels of significance), the hypothesis of homogeneity is rejected and one can conclude that one is not measuring an effect of the same size. 9 Wilcoxon's signed rank test (Z) was used to compare FAST scores in patients and controls. All tests are two-tailed.
Results
Groups were well matched (Table 1) . Patients were significantly more impaired than control subjects (n = 200, Z = 8.19, p < 0.001). This effect was sustained even when only those on monotherapy (n = 30, Z = 2.33, p = 0.019), with no past hospitalizations (n = 36, Z = 3.40, p < 0.001) or with no significant depressive symptoms (HAMD < 8; n = 104, Z = 5.34, p < 0.001) were considered. Figure 1 displays the unadjusted impact of BD on age-related functioning. In the regression analyses, age was significantly associated with functioning both in patients (β = 0.377, SE = 0.087, p < 0.001) and control subjects (β = 0.101, SE = 0.039, P = 0.013). These effects were significantly different (Q = 8.37, p = 0.004).
Discussion
Bipolar illness is characterized by a course both cyclic and recurrent, but to what extent it is progressive is still surrounded by considerable controversy. While some argue that there is a lack of evidence of progressive worsening, 10 others argue that accelerated biological ageing does take place in BD. 11 In this study, bipolar disorder was an important effect modifier of age effects on functioning, further characterizing BD as a chronic and impairing illness.
As this was not a population-based sample, extrapolating these findings to less severely affected patients may be problematic. Additionally, controlled longitudinal studies are needed to confirm these differential age-related effects on functioning. Notwithstanding the limitations of the cross-sectional design employed, we did find a significant, noteworthy and independent impact of BD on agerelated functioning.
Emerging evidence suggests that cognition does play a role in these effects as accelerating hippocampal grey matter loss has been prospectively demonstrated in BD. 12 Since an increased allostatic load creates a risk for cognitive decline, 4 may be the end result of cumulative physiologic dysregulation related to medical burden, 13 HPA axis dysfunction, 14 altered immunity, pro-inflammatory 15 and oxidative stress states. 16 These factors may be partially modifiable medical risks and potential targets to reduce increasing morbidity and impairment in bipolar disorder.
